Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Natural Health Trends (NHTC) Cash & Equivalents (2016 - 2025)

Natural Health Trends' Cash & Equivalents history spans 16 years, with the latest figure at $917000.0 for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 93.22% year-over-year to $917000.0; the TTM value through Dec 2025 reached $917000.0, down 93.22%, while the annual FY2025 figure was $917000.0, 93.22% down from the prior year.
  • Cash & Equivalents reached $917000.0 in Q4 2025 per NHTC's latest filing, down from $14.3 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $90.7 million in Q1 2021 to a low of $917000.0 in Q4 2025.
  • Average Cash & Equivalents over 5 years is $50.3 million, with a median of $60.0 million recorded in 2023.
  • Peak YoY movement for Cash & Equivalents: decreased 5.38% in 2021, then crashed 93.22% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $84.4 million in 2021, then decreased by 17.33% to $69.7 million in 2022, then fell by 19.4% to $56.2 million in 2023, then crashed by 75.93% to $13.5 million in 2024, then plummeted by 93.22% to $917000.0 in 2025.
  • Per Business Quant, the three most recent readings for NHTC's Cash & Equivalents are $917000.0 (Q4 2025), $14.3 million (Q3 2025), and $10.5 million (Q2 2025).